InjuryBoard Sarasota Archives

• Heart Valve Injury Leads Valeant to Pull Permax from Market

  Joe Saunders | March 30, 2007 12:49 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Two studies linking the Parkinson's drug Permax with heart valve damage have resulted in Valeant Pharmaceuticals International pulling the once popular drug from the market. The FDA had asked the drug manufacturer to discontinue marketing the product after the heart valve injury studies. If you are taking or have taken Permax for Parkinson's disease, you should consult your physician for...

• Parkinson's Drug Permax Found to Increase Cardiac Valve Problems

  Joe Saunders | March 17, 2007 10:53 AM | 0 Comments
  Category: FDA & Prescription Drugs

  The journal Drug Injury Watch reports that "new study published in the March 2007 issue of the medical journal Archives of Neurology provides further support to the theory that the long-term use of Permax (pergolide) for Parkinson's disease increases the risk of valvulopathy, primarily cardiac valve regurgitation. In comparison, the same study found that Mirapex (pramipexole) and Requip...

• FDA Warns Sleep Aid Manufacturers

  Joe Saunders | March 15, 2007 9:11 AM | 0 Comments
  Category: FDA & Prescription Drugs

  The FDA has told manufacturers of certain sleep aids that they must put stronger warnings on their labels in order to advise consumers of the possible side effects. The products include the popular Lunesta and Ambien.

• Bile Duct Stents Draw FDA Scrutiny

  Joe Saunders | March 14, 2007 8:09 AM | 0 Comments
  Category: Medical Malpractice

  Th FDA wants to meet with the manufacturers of bile duct stents regarding their "off label" use for surgical applications. The stents are the latest drug or medical device to draw the attention of the FDA for inappropriate, or at least, unapproved use. The unapproved or off label uses comes as a direct result of the companies' overly aggressive marketing tactics.

• CNN Anchor Thomas Roberts Tells His Tale of Abuse

  Joe Saunders | March 13, 2007 1:33 PM | 0 Comments
  Category: Miscellaneous

  For Thomas Roberts, the abuse remained in the shadows. As a successful CNN news anchor, Roberts had buried the hurt, anger, and shame of the abuse-even from himself. Finally, after suffering in silence and fear for 20 years, Roberts came forth and told his tale of horror. Many sexual abuse survivors tell similar tales. They are fearful of recrimination, rejection, and most of all, once again...

• Anemia Drugs Get Black Box Warning from FDA

  Joe Saunders | March 13, 2007 10:00 AM | 0 Comments
  Category: FDA & Prescription Drugs

  The FDA has issued a "black box" warning concerning a family of anemia drugs that have high cancer and heart risks associated with them. The news was a particularly harsh blow to Amgen. The biotech giant alone accounted for $5.3 billion in U.S. sales from its best-selling products Aranesp and Epogen in 2006. Johnson & Johnson's Procrit fetched another $2 billion in U.S. sales. Roche Group AG,...

• Peanut Butter Recall Extended to 2004

  Joe Saunders | March 12, 2007 10:08 PM | 0 Comments
  Category: Defective & Dangerous Products

  The Peter Pan peanut butter recall has been extended to peanut butter manufactured as far back as October 2004. The outbreak of salmonella related to peanut butter has so far sickened 290 people from 39 states. No deaths have been reported.

• Peanut Butter Recall Spreads to Candy, Ice Cream

  Joe Saunders | March 02, 2007 4:57 PM | 0 Comments
  Category: Defective & Dangerous Products

  In a new warning by the FDA, the peanut butter recall has spread to ice cream manufacturers and the makers of other dessert toppings. The salmonella tainted peanut butter originally found in the ConAgra plant was also shipped to a plant in Humboldt Tennessee where bulk peanut butter is sold to such stores as Carvel and Sonic restaurants.